Rosalind Advisors »

Vor Biopharma shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 700k 17.84

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Xeris Pharmaceuticals (XERS)
Fennec Pharmaceuticals (FENC)
Savara (SVRA)
Vaxcyte (PCVX)
Eyepoint Pharmaceuticals Com New (EYPT)
X4 Pharmaceuticals Com New (XFOR)
Vor Biopharma Com New (VOR)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Cybin Com New (HELP)
Cg Oncology (CGON)
Inspiremd (NSPR)

View all positions for Rosalind Advisors

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
Caligan Partners
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
FMR
Vanguard Capital Management
Marshall Wace
State Street Corporation
BlackRock
Vanguard Group
Logos Global Management

View all funds holding Vor Biopharma